Drogen Pharma Private Limited
About Drogen Pharma Private Limited
Data last updated:
Drogen Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 22 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC291557. Its GSTIN is 30AAGCD0340M1Z2 (Goa).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors Arun Vasant Kutumbe and Poonam Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 9 Snehvardhini Sonawala Cross Road No.1 Near Post Office Goregaon( E), Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2023, the company reported a revenue of ₹62.46 Lakh, a decline of 77% compared to the previous year. For the same year it recorded a net loss of ₹7.79 Lakh (net margin -12.5%) and EBITDA of -₹46,571 (EBITDA margin -0.7%). Revenue has grown at a compounded annual rate (CAGR) of 88% over three years.
The company has about 24 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Drogen Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address9 Snehvardhini Sonawala Cross Road No.1 Near Post Office Goregaon( E), Mumbai, Maharashtra, India – 400063
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Drogen Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Drogen Pharma Private Limited
FY 2025 filings availableDrogen Pharma Private Limited reported revenue of ₹62.46 Lakh (down 77% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 77% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 88%. EBITDA fell 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹46,571 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.79 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.7% | ||||
| Net Profit Margin | -12.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Drogen Pharma Private Limited, buy the company report.
Board of directors of Drogen Pharma Private Limited
Drogen Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Vasant Kutumbe | Director | 22 Feb 2017 | 9 Years 8 Months | Current |
| Poonam Kumar | Director | 22 Feb 2017 | 9 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Drogen Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Drogen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Drogen Pharma Private Limited has a workforce of 24 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
GST
Drogen Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 30AAGCD0340M1Z2 | Goa | Active | 07 May 2019 |
To see the full GST registrations and return filing status of Drogen Pharma Private Limited, buy the company report.
Recent activity
Drogen Pharma Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Anjani Yogendra Kumar ceased to be Director on 04 Mar 2021.
Frequently asked questions
Drogen Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 22 February 2017 (9+ years old) and is registered under CIN U74999MH2017PTC291557.
Drogen Pharma has 2 current directors:
- Arun Vasant Kutumbe - Director
- Poonam Kumar - Director
The latest financial statements of Drogen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Drogen Pharma is 30AAGCD0340M1Z2, registered in Goa.
The CIN (Corporate Identification Number) of Drogen Pharma is U74999MH2017PTC291557. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Drogen Pharma was incorporated on 22 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Anjani Yogendra Kumar ceased to be Director on 04 Mar 2021. Davinder Marwah Singh ceased to be Director on 26 Mar 2019. Arun Vasant Kutumbe was appointed as Director on 22 Feb 2017. Drogen Pharma has 4 board changes on record in total.
The registered office of Drogen Pharma is at 9 Snehvardhini Sonawala Cross Road No.1 Near Post Office Goregaon E, Mumbai, Maharashtra, India – 400063.
Drogen Pharma operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Drogen Pharma is compliant as of 01 September 2026. The company is actively filing with the Registrar of Companies.